8-K//Current report
Theravance Biopharma, Inc. 8-K
Accession 0001104659-25-056996
$TBPHCIK 0001583107operating
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:03 AM ET
Size
189.7 KB
Accession
0001104659-25-056996
Documents
- 8-Ktm2517353d1_8k.htmPrimary
FORM 8-K
- EX-101.SCHtbph-20250605.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABtbph-20250605_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREtbph-20250605_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-25-056996-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLtm2517353d1_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001583107
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 6:03 AM ET
- Size
- 189.7 KB